The Functional Difference of Dendritic Cells in HBeAg Negative Chronic Hepatitis B Patients with Three Different Spleen Deficiency Syndromes and the Therapeutic Evaluation of Chinese Medicine Intervention Based on Syndrome Differentiation

Table 3

The comparison of liver enzymes and HBV-DNA levels in HBeAg negative CHB patients before and after treatment.

Group	ALT (U/L)	AST (U/L)	TBIL (umol/L)	HBV-DNA (IU/ML)
A
Before	85.34±15.14	71.26±22.34	14.68±4.34	2.23𝐸+7±4.35𝐸+5
After	50.36±8.53^#	43.78±11.25^#	13.53±6.29	1.98𝐸+7±2.97𝐸+6
B
Before	91.06±16.20	77.13±17.21	17.54±6.85	1.47𝐸+7±3.96𝐸+5
After	54.67±9.15^#	48.56±13.21^#	15.83±7.61	4.32𝐸+6±1.24𝐸+5^∗
C
Before	83.94±17.53	69.38±23.16	18.65±5.38	2.30𝐸+7±4.63𝐸+5
After	49.86±7.33^#	39.66±9.64^#	14.79±8.35	8.73𝐸+6±4.16𝐸+5^∗

^∗𝑃<0.05, compared to group C; ^#𝑃<0.05, compared to baseline.